The importance of contractile reserve in patients with resynchronization therapy

Česká verzia

Authors: P. Muríň; P. Mitro; G. Valočik; B. Stančák
Authors place of work: Kardiologická klinika Lekárskej fakulty UPJŠ a VÚSCH, a. s., Košice, Slovenská republika, prednosta doc. MUDr. Branislav Stančák, CSc.
Published in the journal: Vnitř Lék 2012; 58(1): 13-17
Category: Original Contributions

Summary

Introduction:
Contractile reserve of the myocardium is a strong prognostic factor in patients with heart failure. The presence of a significant amount of myocardial fibrosis might lead to insufficient response to resynchronization therapy We assumed that pre-implantation examination of global contractile reserve will allow prediction of the response to resynchronization treatment.

Methods:
25 symptomatic patients (NYHA III) with severe systolic dysfunction [ejection fraction (EF) 28.9 ± 6.9%] with signs of electric asynchrony (QRS ≥ 120 ms) went through dobutamine echocardiography prior to resynchronization treatment. The global contractile reserve was determined from the change to EF at rest and at the peak of pharmacological burden (40 μg/kg/min). Patients with a rise in EF of more than 5% and/or endsystolic volume reduction of more than 15% after three months of resynchronization treatment were considered responders.

Results:
Compared to non-responders, responders had higher increase in EF during dobutamine stress echocardiography (Δ 12.8 ± 7.4 % vs. Δ 3.4 ± 7.1 %, p = 0.0042). Three months from the initiation of resynchronization therapy, the global myocardial contractile reserve also significantly correlated with EF increase (r = 0.67, p = 0.007). The 6% increase in EF during dobutamin stress echocardiography predicted responders to resynchronization therapy with 83% sensitivity and 75% specificity.

Conclusion:
The global contractile reserve may play an important role in prediction of a response to resynchronization therapy.

Key words:
global contractile reserve – resynchronization therapy – dobutamin stress echocardiography – heart failure

Zdroje

1. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–1549.

2. Novak M, Lipoldova J, Kamaryt P et al. Cardiac resynchronization therapy. Midterm follow-up of 128 patients. Bratisl Lek Listy 2007; 108: 445–452.

3. Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005; 112: 1580–1586.

4. Van Bommel RJ, Mollema SA, Borleffs CJ et al. Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2011; 57: 549–555.

5. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999; 33: 1848–1854.

6. Ramahi TM, Longo MD, Cadariu AR et al. Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy. J Am Coll Cardiol 2001; 37: 818–824.

7. Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102: 3053–3059.

8. Ukkonen H, Sundell J, Knuuti J. Effects of CRT on myocardial innervations, perfusion and metabolism. Europace 2008; 10 (Suppl 3): iii114–iii117.

9. Samol A, Klotz S, Stypmann J et al. QRS integral: an electrocardiographic indicator of mechanical interventricular asynchrony. J Electrocardiol 2010; 43: 242–250.

10. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.

11. Rajappan K, Rimoldi OE, Dutka DP et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002; 105: 470–476.

12. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39: 194–201.

13. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002; 105: 438–445.

14. Prinzen FW, Hunter WC, Wyman BT et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999; 33: 1735–1742.

15. Nowak B, Sinha AM, Schaefer WM et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003; 41: 1523–1528.

16. Neri G, Zanco P, Zanon F et al. Effect of biventricular pacing on metabolism and perfusion in patients affected by dilated cardiomyopathy and left bundle branch block: evaluation by positron emission tomography. Europace 2003; 5: 111–115.

17. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007; 153: 105–112.

18. Riedlbauchova L, Brunken R, Jaber WA et al. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009; 20: 50–57.

19. Ramahi TM, Longo MD, Cadariu AR et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Eur Heart J 2001; 22: 849–856.

20. Ypenburg C, Sieders A, Bleeker GB et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J 2007; 154: 1160–1165.

21. Dúbrava J. Viabilný myokard 1. časť. Patofyziológia a diagnostika. Cardiol 1999; 8: 311–319.

22. Lancellotti P, Senechal M, Moonen M et al. Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy. Eur J Echocardiogr 2009; 10: 663–668.